Mutschler 2022 MitoFit: Difference between revisions
No edit summary |
Tindle Lisa (talk | contribs) No edit summary |
||
Line 2: | Line 2: | ||
{{Publication | {{Publication | ||
|title=Mutschler R (2022) Membranes as therapeutic targets - liposomes as therapeutic options. MitoFit Preprints 2022.10. https://doi.org/10.26124/mitofit:2022-0010 | |title=Mutschler R (2022) Membranes as therapeutic targets - liposomes as therapeutic options. MitoFit Preprints 2022.10. https://doi.org/10.26124/mitofit:2022-0010 | ||
|info=[[File:MitoFit Preprints pdf.png|left|160px|link=|MitoFit pdf]] [ Membranes as therapeutic targets - liposomes as therapeutic options]<br/> | |info=[[File:MitoFit Preprints pdf.png|left|160px|link=https://wiki.oroboros.at/images/4/42/Mutschler_2022_MitoFit.pdf|MitoFit pdf]] [https://wiki.oroboros.at/images/4/42/Mutschler_2022_MitoFit.pdf Membranes as therapeutic targets - liposomes as therapeutic options]<br/> | ||
|authors=Mutschler Rainer | |authors=Mutschler Rainer | ||
|year=2022-04- | |year=2022-04- | ||
Line 11: | Line 11: | ||
}} | }} | ||
Revision as of 13:09, 7 April 2022
Mutschler 2022 MitoFit
Mutschler R (2022) Membranes as therapeutic targets - liposomes as therapeutic options. MitoFit Preprints 2022.10. https://doi.org/10.26124/mitofit:2022-0010 |
ยป
Membranes as therapeutic targets - liposomes as therapeutic options
Mutschler Rainer (2022-04-) MitoFit Prep
Abstract: Damaged or chemically altered membranes are highly likely to play a central role at the molecular level in many chronic and acute diseases as well as in aging. Damage is often related to inflammatory processes that release large amounts of radical oxygen species (ROS). For several years, membrane replacement has been investigated as a therapeutic option for various diseases. Furthermore, liposomes represent potentially valuable tools for this purpose to force the integration of membrane material into the body's own tissue. Unfortunately, however, this method has not yet arrived in practice. Therefore, we have made our own efforts to establish membrane replacement in our practice, including the therapeutic use of liposomal products of high quality. Here we report on two successfully treated cases.
โข Keywords: membranes, liposomes, phospholipids, phosphatidylcholine, membrane replacement therapy, liposomal formulations, mitochondria, adducts, detoxification
โข Bioblast editor: Tindle-Solomon L
Labels: MiParea: Patients Pathology: Inherited, Parkinson's Stress:Oxidative stress;RONS Organism: Human
membranes, liposomes, lipids